chr5-134751145-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001745.4(CAMLG):c.*195T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00604 in 500,656 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0049 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0065 ( 16 hom. )
Consequence
CAMLG
NM_001745.4 3_prime_UTR
NM_001745.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.14
Genes affected
CAMLG (HGNC:1471): (calcium modulating ligand) The immunosuppressant drug cyclosporin A blocks a calcium-dependent signal from the T-cell receptor (TCR) that normally leads to T-cell activation. When bound to cyclophilin B, cyclosporin A binds and inactivates the key signaling intermediate calcineurin. The protein encoded by this gene functions similarly to cyclosporin A, binding to cyclophilin B and acting downstream of the TCR and upstream of calcineurin by causing an influx of calcium. This integral membrane protein appears to be a new participant in the calcium signal transduction pathway, implicating cyclophilin B in calcium signaling, even in the absence of cyclosporin. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BS2
High Homozygotes in GnomAdExome4 at 16 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00489 AC: 745AN: 152220Hom.: 1 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
745
AN:
152220
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00654 AC: 2278AN: 348318Hom.: 16 Cov.: 3 AF XY: 0.00662 AC XY: 1193AN XY: 180306 show subpopulations
GnomAD4 exome
AF:
AC:
2278
AN:
348318
Hom.:
Cov.:
3
AF XY:
AC XY:
1193
AN XY:
180306
show subpopulations
African (AFR)
AF:
AC:
23
AN:
11056
American (AMR)
AF:
AC:
61
AN:
13886
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
11414
East Asian (EAS)
AF:
AC:
1
AN:
28042
South Asian (SAS)
AF:
AC:
248
AN:
23844
European-Finnish (FIN)
AF:
AC:
49
AN:
22578
Middle Eastern (MID)
AF:
AC:
26
AN:
1596
European-Non Finnish (NFE)
AF:
AC:
1738
AN:
214744
Other (OTH)
AF:
AC:
127
AN:
21158
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
104
208
313
417
521
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00488 AC: 744AN: 152338Hom.: 1 Cov.: 32 AF XY: 0.00452 AC XY: 337AN XY: 74494 show subpopulations
GnomAD4 genome
AF:
AC:
744
AN:
152338
Hom.:
Cov.:
32
AF XY:
AC XY:
337
AN XY:
74494
show subpopulations
African (AFR)
AF:
AC:
55
AN:
41586
American (AMR)
AF:
AC:
71
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
3472
East Asian (EAS)
AF:
AC:
1
AN:
5192
South Asian (SAS)
AF:
AC:
49
AN:
4832
European-Finnish (FIN)
AF:
AC:
8
AN:
10626
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
543
AN:
68034
Other (OTH)
AF:
AC:
12
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
40
80
120
160
200
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at